Literature DB >> 25816842

Shank1 regulates excitatory synaptic transmission in mouse hippocampal parvalbumin-expressing inhibitory interneurons.

Wenjie Mao1, Takuya Watanabe, Sukhee Cho, Jeffrey L Frost, Tina Truong, Xiaohu Zhao, Kensuke Futai.   

Abstract

The Shank genes (SHANK1, 2, 3) encode scaffold proteins highly enriched in postsynaptic densities where they regulate synaptic structure in spiny neurons. Mutations in human Shank genes are linked to autism spectrum disorder and schizophrenia. Shank1 mutant mice exhibit intriguing cognitive phenotypes reminiscent of individuals with autism spectrum disorder. However, the molecular mechanisms leading to the human pathophysiological phenotypes and mouse behaviors have not been elucidated. In this study it is shown that Shank1 protein is highly localized in parvalbumin-expressing (PV+) fast-spiking inhibitory interneurons in the hippocampus. Importantly, a lack of Shank1 in hippocampal CA1 PV+ neurons reduced excitatory synaptic inputs and inhibitory synaptic outputs to pyramidal neurons. Furthermore, it is demonstrated that hippocampal CA1 pyramidal neurons in Shank1 mutant mice exhibit a shift in the excitatory and inhibitory balance (E-I balance), a pathophysiological hallmark of autism spectrum disorder. The mutant mice also exhibit lower expression of gephyrin (a scaffold component of inhibitory synapses), supporting the dysregulation of E-I balance in the hippocampus. These results suggest that Shank1 scaffold in PV+ interneurons regulates excitatory synaptic strength and participates in the maintenance of E-I balance in excitatory neurons.
© 2015 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  GABAergic synapse; excitatory synapse; hippocampus; interneurons; synaptic transmission

Mesh:

Substances:

Year:  2015        PMID: 25816842      PMCID: PMC4405481          DOI: 10.1111/ejn.12877

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  55 in total

Review 1.  Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins.

Authors:  Guillermo M Elias; Roger A Nicoll
Journal:  Trends Cell Biol       Date:  2007-07-20       Impact factor: 20.808

2.  The BK-mediated fAHP is modulated by learning a hippocampus-dependent task.

Authors:  Elizabeth A Matthews; Aldis P Weible; Samit Shah; John F Disterhoft
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-17       Impact factor: 11.205

Review 3.  Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1.

Authors:  Hanna Jaaro-Peled; Akiko Hayashi-Takagi; Saurav Seshadri; Atsushi Kamiya; Nicholas J Brandon; Akira Sawa
Journal:  Trends Neurosci       Date:  2009-08-26       Impact factor: 13.837

Review 4.  Molecular mechanisms underlying neural circuit formation.

Authors:  Bai Lu; Kuan Hong Wang; Akinao Nose
Journal:  Curr Opin Neurobiol       Date:  2009-05-18       Impact factor: 6.627

5.  Key role of the postsynaptic density scaffold proteins Shank and Homer in the functional architecture of Ca2+ homeostasis at dendritic spines in hippocampal neurons.

Authors:  Carlo Sala; Gautier Roussignol; Jacopo Meldolesi; Laurent Fagni
Journal:  J Neurosci       Date:  2005-05-04       Impact factor: 6.167

6.  Neocortical excitation/inhibition balance in information processing and social dysfunction.

Authors:  Ofer Yizhar; Lief E Fenno; Matthias Prigge; Franziska Schneider; Thomas J Davidson; Daniel J O'Shea; Vikaas S Sohal; Inbal Goshen; Joel Finkelstein; Jeanne T Paz; Katja Stehfest; Roman Fudim; Charu Ramakrishnan; John R Huguenard; Peter Hegemann; Karl Deisseroth
Journal:  Nature       Date:  2011-07-27       Impact factor: 49.962

7.  Anti-Hebbian long-term potentiation in the hippocampal feedback inhibitory circuit.

Authors:  Karri P Lamsa; Joost H Heeroma; Peter Somogyi; Dmitri A Rusakov; Dimitri M Kullmann
Journal:  Science       Date:  2007-03-02       Impact factor: 47.728

8.  Gephyrin regulates the cell surface dynamics of synaptic GABAA receptors.

Authors:  Tija C Jacob; Yury D Bogdanov; Christopher Magnus; Richard S Saliba; Josef T Kittler; Philip G Haydon; Stephen J Moss
Journal:  J Neurosci       Date:  2005-11-09       Impact factor: 6.167

9.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction.

Authors:  João Peça; Cátia Feliciano; Jonathan T Ting; Wenting Wang; Michael F Wells; Talaignair N Venkatraman; Christopher D Lascola; Zhanyan Fu; Guoping Feng
Journal:  Nature       Date:  2011-03-20       Impact factor: 49.962

Review 10.  Autism: a "critical period" disorder?

Authors:  Jocelyn J LeBlanc; Michela Fagiolini
Journal:  Neural Plast       Date:  2011-08-03       Impact factor: 3.599

View more
  21 in total

Review 1.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 2.  Hippocampal deficits in neurodevelopmental disorders.

Authors:  Yue Li; Minjie Shen; Michael E Stockton; Xinyu Zhao
Journal:  Neurobiol Learn Mem       Date:  2018-10-12       Impact factor: 2.877

Review 3.  SHANK proteins: roles at the synapse and in autism spectrum disorder.

Authors:  Patricia Monteiro; Guoping Feng
Journal:  Nat Rev Neurosci       Date:  2017-02-09       Impact factor: 34.870

Review 4.  Cortical interneurons in autism.

Authors:  Anis Contractor; Iryna M Ethell; Carlos Portera-Cailliau
Journal:  Nat Neurosci       Date:  2021-11-29       Impact factor: 24.884

Review 5.  Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications.

Authors:  Jan Philipp Delling; Tobias M Boeckers
Journal:  J Neurodev Disord       Date:  2021-11-16       Impact factor: 4.025

6.  Truncating variants in the SHANK1 gene are associated with a spectrum of neurodevelopmental disorders.

Authors:  Halie J May; Jaehoon Jeong; Anya Revah-Politi; Julie S Cohen; Anna Chassevent; Julia Baptista; Evan H Baugh; Louise Bier; Armand Bottani; Maria Teresa Carminho A Rodrigues; Charles Conlon; Joel Fluss; Michel Guipponi; Chong Ae Kim; Naomichi Matsumoto; Richard Person; Michelle Primiano; Julia Rankin; Marwan Shinawi; Constance Smith-Hicks; Aida Telegrafi; Samantha Toy; Yuri Uchiyama; Vimla Aggarwal; David B Goldstein; Katherine W Roche; Kwame Anyane-Yeboa
Journal:  Genet Med       Date:  2021-06-10       Impact factor: 8.822

Review 7.  Parvalbumin interneuron vulnerability and brain disorders.

Authors:  Jacob B Ruden; Laura L Dugan; Christine Konradi
Journal:  Neuropsychopharmacology       Date:  2020-07-28       Impact factor: 7.853

8.  Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans.

Authors:  Jamie L Courtland; Tyler Wa Bradshaw; Greg Waitt; Erik J Soderblom; Tricia Ho; Anna Rajab; Ricardo Vancini; Il Hwan Kim; Scott H Soderling
Journal:  Elife       Date:  2021-03-22       Impact factor: 8.713

9.  Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population.

Authors:  Ikuo Otsuka; Yuichiro Watanabe; Akitoyo Hishimoto; Shuken Boku; Kentaro Mouri; Kyoichi Shiroiwa; Satoshi Okazaki; Ayako Nunokawa; Osamu Shirakawa; Toshiyuki Someya; Ichiro Sora
Journal:  Neuropsychiatr Dis Treat       Date:  2015-06-02       Impact factor: 2.570

10.  Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism.

Authors:  Federica Filice; Karl Jakob Vörckel; Ayse Özge Sungur; Markus Wöhr; Beat Schwaller
Journal:  Mol Brain       Date:  2016-01-27       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.